255 related articles for article (PubMed ID: 24211136)
21. Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.
Zhang X; Shen L; Liu Q; Hou L; Huang L
J Control Release; 2019 Sep; 309():173-180. PubMed ID: 31362079
[TBL] [Abstract][Full Text] [Related]
22. Targeting phosphoinositide 3-kinase δ for allergic asthma.
Rowan WC; Smith JL; Affleck K; Amour A
Biochem Soc Trans; 2012 Feb; 40(1):240-5. PubMed ID: 22260698
[TBL] [Abstract][Full Text] [Related]
23. PI3K inhibition in inflammation: Toward tailored therapies for specific diseases.
Ghigo A; Damilano F; Braccini L; Hirsch E
Bioessays; 2010 Mar; 32(3):185-196. PubMed ID: 20162662
[TBL] [Abstract][Full Text] [Related]
24. Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor.
Cai Y; Yu J; Ren P; He J; Wu Z; Xiao K; Jia H; Wang J; Sai Y; Dai G; Li X; Su W; Ngo K; Castro G; Acton PD; Fung-Leung WP; Edwards JP; Venable J; Rao TS
Pharmacol Res Perspect; 2020 Feb; 8(1):e00559. PubMed ID: 31956418
[TBL] [Abstract][Full Text] [Related]
25. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
26. Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease.
Sunose M; Bell K; Ellard K; Bergamini G; Neubauer G; Werner T; Ramsden N
Bioorg Med Chem Lett; 2012 Jul; 22(14):4613-8. PubMed ID: 22726925
[TBL] [Abstract][Full Text] [Related]
27. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity.
Yun TJ; Harning EK; Giza K; Rabah D; Li P; Arndt JW; Luchetti D; Biamonte MA; Shi J; Lundgren K; Manning A; Kehry MR
J Immunol; 2011 Jan; 186(1):563-75. PubMed ID: 21131419
[TBL] [Abstract][Full Text] [Related]
28. [Coordinated regulation of PI3K and Notch signal pathways in the activation and proliferation of CD4(+)T lymphocytes in asthma mice].
Nie Y; Yang BK; Sheng AQ; Zhang WX; Li CC
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3532-6. PubMed ID: 24521897
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
[TBL] [Abstract][Full Text] [Related]
30. HIF-1α inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium.
Kim SR; Lee KS; Park HS; Park SJ; Min KH; Moon H; Puri KD; Lee YC
Eur J Immunol; 2010 Oct; 40(10):2858-69. PubMed ID: 20827786
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
[TBL] [Abstract][Full Text] [Related]
33. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
34. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases.
Oka Y; Yabuuchi T; Oi T; Kuroda S; Fujii Y; Ohtake H; Inoue T; Wakahara S; Kimura K; Fujita K; Endo M; Taguchi K; Sekiguchi Y
Bioorg Med Chem; 2013 Dec; 21(24):7578-83. PubMed ID: 24262886
[TBL] [Abstract][Full Text] [Related]
35. Defining Bronchial Asthma with Phosphoinositide 3-Kinase Delta Activation: Towards Endotype-Driven Management.
Jeong JS; Kim JS; Kim SR; Lee YC
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323822
[TBL] [Abstract][Full Text] [Related]
36. Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.
Sinagra T; Tamburella A; Urso V; Siarkos I; Drago F; Bucolo C; Salomone S
Biochem Pharmacol; 2013 Feb; 85(4):551-9. PubMed ID: 23194750
[TBL] [Abstract][Full Text] [Related]
37. Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway.
Bruce I; Akhlaq M; Bloomfield GC; Budd E; Cox B; Cuenoud B; Finan P; Gedeck P; Hatto J; Hayler JF; Head D; Keller T; Kirman L; Leblanc C; Le Grand D; McCarthy C; O'Connor D; Owen C; Oza MS; Pilgrim G; Press NE; Sviridenko L; Whitehead L
Bioorg Med Chem Lett; 2012 Sep; 22(17):5445-50. PubMed ID: 22863202
[TBL] [Abstract][Full Text] [Related]
38. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion.
Barber DF; Bartolomé A; Hernandez C; Flores JM; Fernandez-Arias C; Rodríguez-Borlado L; Hirsch E; Wymann M; Balomenos D; Carrera AC
J Immunol; 2006 Jan; 176(1):589-93. PubMed ID: 16365454
[TBL] [Abstract][Full Text] [Related]
39. Do gamma delta T cells play an important role in autoimmune disease?
Bröker BM; Smith MD; Yoshino S; Lydyard PM; Emmrich F
Behring Inst Mitt; 1991 Feb; (88):43-51. PubMed ID: 1828664
[TBL] [Abstract][Full Text] [Related]
40. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.
Wang Y; Yoshioka K; Azam MA; Takuwa N; Sakurada S; Kayaba Y; Sugimoto N; Inoki I; Kimura T; Kuwaki T; Takuwa Y
Biochem J; 2006 Mar; 394(Pt 3):581-92. PubMed ID: 16336212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
